NEW (deerfield)
Xenon to Report Q1 2025 Financial Results on May 12, 2025
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
Xenon to Present at Stifel 2025 Virtual CNS Forum